A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 1-2, 2010, Pages 110-115

  Bromberg, Mark B ^a   Brownell, Alexander A ^a   Forshew, Dallas A ^b   Swenson, Michael ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c Central Wyoming College   (United States)

Author keywords

ALS; Amyotrophic lateral sclerosis; DME; Durable medical equipment

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASSISTED VENTILATION; COST EFFECTIVENESS ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL RECORD REVIEW; NON INVASIVE PROCEDURE; ORTHOSIS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; STOMACH TUBE; WALKING AID; WHEELCHAIR;

AMBULATORY CARE; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; DURABLE MEDICAL EQUIPMENT; ENTERAL NUTRITION; FEMALE; HEALTH CARE COSTS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEDICAL RECORDS; MIDDLE AGED; NEEDS ASSESSMENT; POSITIVE-PRESSURE RESPIRATION; PREDICTIVE VALUE OF TESTS; TIME FACTORS; UTAH; WHEELCHAIRS;

EID: 77649324425     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960902835970     Document Type: Article

References (11)

1. Traynor B, Codd M, Corr B, Forde C, Frost E, Hardiman O. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria. A population-based study. Archives of Neurology. 2000;57: 1171-6.
2. Klein L, Forshew D. The economic impact of ALS. Neurology. 1996;47(Suppl 2):S126-9.
3. Miller R, Rosenberg J, Gelinas D, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Neurology. 1999;52:1311-23.
4. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler. 2007;8:195-213.
5. Brooks B, Depaul R, Tan Y, Sanjak M, Sufit R, Robbins J. Motor neuron disease. In: Porter R, Schoenberg B, editors. Controlled clinical trials in neurological disease. Norwell, MA: Kluwer Academic Publishers, 1990. p. 249-81.
6. Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology. 1996;47 (Suppl 2):S71-81, discussion S2.
7. Kimura F, Fujimura C, Ishida S, Hosokawa T, Sato T, Nakajima H, et al. A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS. Rinsho Shinkeigakus. 2007;47:140-6.
8. Pinto S, Pinto A, de Carvalho M. Do bulbar onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal onset amyotrophic lateral sclerosis patients? Eura Medicophys. 2007;43:505-9.
9. Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology. 1999;53: 1071-6.
10. Albert SM, Murphy PL, Del Bene ML, Rowland LP. Prospective study of palliative care in ALS: choice, timing, outcomes. J Neurol Sci. 1999;169:108-13.
11. Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:163-7.